Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Mizoguchi

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Psychiatry Research|May 7, 2020
Changes in interleukin-1 beta induced by rTMS are significantly correlated with partial improvement of cognitive dysfunction in treatment-resistant depression: a pilot studyHiroshi Tateishi, Yoshito Mizoguchi, Atsushi Kawaguchi, et al.
Schizophrenia Research|September 12, 2016
Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7Mina Sato-Kasai, Takahiro A Kato, Masahiro Ohgidani, et al.
Peptides|April 13, 2024
Negative association between basal oxytocin and oxytocin changes after repetitive transcranial magnetic stimulation in patients with treatment-resistant depressionRyohei Kojima, Hiroshi Tateishi, Hiroko Kunitake, et al.
Psychiatry Research|January 15, 2019
Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilitiesChie Aita, Yoshito Mizoguchi, Miwako Yamamoto, et al.
The Journal of Biological Chemistry|June 7, 2006
Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibitionTakashi Kanematsu, Atsushi Yasunaga, Yoshito Mizoguchi, et al.
Schizophrenia Research|April 19, 2011
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microgliaTakahiro A Kato, Akira Monji, Keiji Yasukawa, et al.
Psychiatry Research|May 20, 2022
Changes in the metabolites of cerebrospinal fluid induced by rTMS in treatment-resistant depression: A pilot studyHiroshi Tateishi, Daiki Setoyama, Takahiro A Kato, et al.
Journal of Psychiatric Research|April 17, 2021
The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: A pilot studyHiroshi Tateishi, Daiki Setoyama, Dongchon Kang, et al.
International Journal of Geriatric Psychiatry|May 17, 2024
Association depressive symptoms with memory function and social capital before and during COVID-19 in community-dwelling older adults in rural Japan: A retrospective study with a longitudinal dataYutaka Kunitake, Yoshiomi Imamura, Hiroko Kunitake, et al.
Neuropsychopharmacology Reports|March 12, 2023
Serum soluble triggering receptor expressed on myeloid cells-2 was not altered by rTMS in patients with treatment-resistant depressionHiroshi Tateishi, Jun Matsushima, Hiroko Kunitake, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Psychiatry Research|May 7, 2020
Changes in interleukin-1 beta induced by rTMS are significantly correlated with partial improvement of cognitive dysfunction in treatment-resistant depression: a pilot studyHiroshi Tateishi, Yoshito Mizoguchi, Atsushi Kawaguchi, et al.
Schizophrenia Research|September 12, 2016
Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7Mina Sato-Kasai, Takahiro A Kato, Masahiro Ohgidani, et al.
Peptides|April 13, 2024
Negative association between basal oxytocin and oxytocin changes after repetitive transcranial magnetic stimulation in patients with treatment-resistant depressionRyohei Kojima, Hiroshi Tateishi, Hiroko Kunitake, et al.
Psychiatry Research|January 15, 2019
Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilitiesChie Aita, Yoshito Mizoguchi, Miwako Yamamoto, et al.
The Journal of Biological Chemistry|June 7, 2006
Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibitionTakashi Kanematsu, Atsushi Yasunaga, Yoshito Mizoguchi, et al.
Schizophrenia Research|April 19, 2011
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microgliaTakahiro A Kato, Akira Monji, Keiji Yasukawa, et al.
Psychiatry Research|May 20, 2022
Changes in the metabolites of cerebrospinal fluid induced by rTMS in treatment-resistant depression: A pilot studyHiroshi Tateishi, Daiki Setoyama, Takahiro A Kato, et al.
Journal of Psychiatric Research|April 17, 2021
The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: A pilot studyHiroshi Tateishi, Daiki Setoyama, Dongchon Kang, et al.
International Journal of Geriatric Psychiatry|May 17, 2024
Association depressive symptoms with memory function and social capital before and during COVID-19 in community-dwelling older adults in rural Japan: A retrospective study with a longitudinal dataYutaka Kunitake, Yoshiomi Imamura, Hiroko Kunitake, et al.
Neuropsychopharmacology Reports|March 12, 2023
Serum soluble triggering receptor expressed on myeloid cells-2 was not altered by rTMS in patients with treatment-resistant depressionHiroshi Tateishi, Jun Matsushima, Hiroko Kunitake, et al.
Pageof 9